Mark Shapiro
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 18
- Chronic Myeloid Leukemia Treatments 16
-
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Juan P. Wisnivesky (5 shared papers)Cynthia Chin (5 shared papers)Todd S. Weiser (4 shared papers)Steven Swanson (4 shared papers)Jörge E. Cortes (12 shared papers)Cameron D. Wright (1 shared paper)Shubin Sheng (1 shared paper)Robert J. Korst (3 shared papers)
- Journals
- Blood (9 papers)Journal of Clinical Oncology (6 papers)The Annals of Thoracic Surgery (3 papers)Current Medical Research and Opinion (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Mark Shapiro
45 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Hematology 339
- Genetics 256
- Pulmonary and Respiratory Medicine 449
- Microbiology 11
- Oncology 369
Countries citing papers authored by Mark Shapiro
This map shows the geographic impact of Mark Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shapiro more than expected).
Fields of papers citing papers by Mark Shapiro
This network shows the impact of papers produced by Mark Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shapiro. The network helps show where Mark Shapiro may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 257 | |
| 2 | 2010 | 155 | |
| 3 | 2009 | 116 | |
| 4 | 2011 | 84 | |
| 5 | 2016 | 70 | |
| 6 | 2013 | 64 | |
| 7 | 2015 | 57 | |
| 8 | 2015 | 55 | |
| 9 | 1953 | 46 | |
| 10 | 2018 | 44 | |
| 11 | 2012 | 43 | |
| 12 | 2016 | 33 | |
| 13 | 2015 | 31 | |
| 14 | 2008 | 29 | |
| 15 | 2014 | 28 | |
| 16 | 2008 | 25 | |
| 17 | 2012 | 25 | |
| 18 | 2008 | 25 | |
| 19 | 2016 | 22 | |
| 20 | 2006 | 21 |
About Mark Shapiro
Mark Shapiro is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Surgery, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (12 papers), Lung Cancer Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (339 citations), Genetics (256 citations), Pulmonary and Respiratory Medicine (449 citations), Microbiology (11 citations) and Oncology (369 citations). Mark Shapiro has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Juan P. Wisnivesky, Cynthia Chin, Todd S. Weiser, Steven Swanson, Jörge E. Cortes, Cameron D. Wright, Shubin Sheng, Robert J. Korst, Hagop M. Kantarjian and Carlo Gambacorti‐Passerini. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Annals of Thoracic Surgery, Current Medical Research and Opinion and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.